On January 14, RH director Mark Demilio sold a block of 2,254 shares in a single transaction valued at approximately $495,880. Following this sale, Demilio’s holding in RH decreased by just over 10%, leaving him with 19,962 shares valued at roughly $4.39 million. The transaction was reported to the SEC in a filing that underscores a notable reduction in insider ownership.

In its most recent quarter, RH reported earnings per share of $1.71 on revenue of $883.8 million, representing year-over-year top-line growth of 8.9% but missing the consensus EPS forecast by $0.42. Despite sustaining revenue momentum, the company posted a net margin of just 3.2% and a return on equity that remained deeply negative at 161.7%, raising concerns about leverage and profitability among investors.

Investor sentiment is mixed following several recent research notes. Morgan Stanley reaffirmed a bullish outlook and lifted its target above prevailing consensus, citing intact revenue growth and the potential for a multiple recovery. Other firms have either cut their objectives or maintained cautious ratings, leading to a wide range of forecasts and a consensus viewpoint that remains neutral. Institutional activity has also been varied, with both large buys and sells reported, offering little clarity on near-term directional catalysts.